🟢 Senti Biosciences is trading 9.43% up in pre-market — no clear catalyst identified

Senti Biosciences is trading 9.43% up at $0.41; no clear company-specific announcement was identified for September 1, 2026.

• The latest major event was the July 15 transaction separating SENTI-202 into a Celadon-controlled private company in exchange for contingent value rights.
• Available coverage does not link that transaction to the move.
• Broader markets are weaker; no reliable pre-market volume data or fresh catalyst was found.